Hantavirus infections are noted for their ability to infect endothelial cells, cause acute thrombocytopenia, and trigger 2 vascular-permeability-based diseases. However, hantavirus infections are not lytic, and the mechanisms by which hantaviruses cause capillary permeability and thrombocytopenia are only partially understood. The role of ␤ 3 integrins in hemostasis and the inactivation of ␤ 3 integrin receptors by pathogenic hantaviruses suggest the involvement of hantaviruses in altered platelet and endothelial cell functions that regulate permeability. Here, we determined that pathogenic hantaviruses bind to quiescent platelets via a ␤ 3 integrin-dependent mechanism. This suggests that platelets may contribute to hantavirus dissemination within infected patients and provides a means by which hantavirus binding to ␤ 3 integrin receptors prevents platelet activation. The ability of hantaviruses to bind platelets further suggested that cell-associated hantaviruses might recruit platelets to the endothelial cell surface. 
Hantaviruses cause two human diseases with prominent effects on vascular permeability, hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS) (54, 55) . Hantaviruses predominantly infect endothelial cells and cause acute thrombocytopenia in both HPS and HFRS patients (9, 17, 35, 37, 45, 64, 65) . Endothelial cells line the vasculature and form a fluid barrier that is the primary determinant of capillary integrity and permeability (3, 19) . Platelets also maintain hemostasis through thrombus formation, and platelet adherence and activation are normally inhibited by endothelial cell signals (2, 8, 12, 52) . As a result, hantavirus infections affect both platelets and endothelial cells which dynamically regulate vascular permeability. Since hantaviruses do not lyse infected endothelial cells, alternative pathogenic mechanisms need to be considered in order explain the vascular leakage observed in HPS and HFRS patients (35, 37, 45, 65) . Although pathogenesis is likely to be a multifactorial process, responses of hantavirus-infected endothelial cells are central to understanding vascular permeability deficits of hantavirus diseases.
Platelets and endothelial cells commonly display ␤ 3 integrins on their surfaces, and ␤ 3 integrins play prominent roles in regulating vascular integrity (6, 8, 11, 12, 30, 53) . ␤ 3 integrins are receptors for pathogenic HPS-and HFRS-causing hantaviruses, while nonpathogenic hantaviruses use ␣ 5 ␤ 1 integrins (24, 26, 40) . Pathogenic hantaviruses bind to plexin, semiphorin, integrin (PSI) domains present on basal, bent conformations of ␤ 3 integrins (39, 58, 67) and inhibit endothelial cell migration on the ␣ v ␤ 3 integrin ligand vitronectin days after infection (23, 49) . ␣ v ␤ 3 integrins normally enhance capillary integrity by regulating endothelial cell responses to vascular endothelial growth factor (VEGF) (6, 30, 51, 53) . In fact, knocking out ␤ 3 integrins results in enhanced endothelial cell permeability in response to VEGF (30, 51, 53) . Similarly, pathogenic hantaviruses block ␤ 3 integrin functions and enhance the permeability of endothelial cells in response to VEGF, but only at late times postinfection (25) . Hantaviruses have been shown to cover the surface of infected VeroE6 cells (28) , and the presence of cell-associated hantavirus provides a potential explanation for the loss of ␤ 3 integrin function and enhanced endothelial cell permeability days after infection (23, 25) . ␣ IIb ␤ 3 integrins are abundantly present on the surface of platelets, where they mediate platelet adherence to fibrinogen and platelet activation (8, 12) . Endothelial cells produce ADPase and prostacyclin, which normally inhibit platelet activation and prevent platelet adherence to the endothelium (34, 44) . How-ever, once activated, platelets are highly adherent to each other and the endothelium, resulting in rapid regulation of vascular leakage (5, 8, 12, 42, 43) . There is little information about the interaction of hantaviruses with platelets, the mechanism of hantavirus-induced thrombocytopenia, or the role of thrombocytopenia in hantavirus disease (13-15, 17, 45, 65) . Cosgriff et al. demonstrated that platelets from HFRS patients have a defect in platelet activation, suggesting that thrombocytopenia results from platelet inactivation rather than from excessive platelet activation and aggregation (14) . Combining this finding with the ability of pathogenic hantaviruses to bind inactive ␤ 3 integrins (49), we rationalized that hantaviruses may bind quiescent platelets and that platelets could be a vehicle for hantavirus dissemination. These data further suggest that cell-associated hantaviruses (28) might recruit quiescent platelets to the surface of infected endothelial cells and fundamentally alter normal endothelial cell interactions. In this report, we investigate the ability of hantaviruses and hantavirus-infected endothelial cells to bind platelets. Our findings provide a vital understanding of hantavirus-platelet interactions, suggest potential mechanisms for hantavirus-induced thrombocytopenia, and demonstrate that hantaviruses alter endothelial cell properties that are likely to contribute to hantavirus disease.
Pathogenic hantaviruses bind platelets. ␤ 3 integrins are receptors for pathogenic hantaviruses, and platelets express ␣ IIb ␤ 3 integrins on their surface (12, 24, 26) . Despite this, there is little information on the interaction of hantaviruses with platelets. We initially determined whether pathogenic hantaviruses are capable of binding to platelets, using an infectivity assay to detect viral adherence. Platelets were harvested in citrate phosphate buffer, separated by centrifugation in the presence of 1 M prostaglandin E1 (PGE 1 ) (5), and further purified using Sepharose 2B chromatography as previously described (5, 27) . Platelet viability was 95% in all experiments, as determined by aggregometer (Chrono-log Corporation) or calcein AM (Invitrogen) uptake. A constant amount of pathogenic Andes virus (ANDV), pathogenic Hantaan virus (HTNV), or nonpathogenic Tula virus (TULV) (10 4 focus-forming units [FFU]) (25) was incubated with freshly purified platelets for 1 h at 37°C. Platelets were pelleted, washed 3 times to remove unbound virus, and resuspended prior to adsorption to VeroE6 monolayers (1 h, 37°C). Monolayers were washed 3 times with Dulbecco's modified Eagle's medium (DMEM) supplemented with 2% fetal calf serum (FCS), and at 1 day postinfection, cells were methanol fixed (100%, Ϫ20°C, 10 min) and the presence of the hantavirus nucleocapsid protein within infected VeroE6 cells was quantitated by immunoperoxidase staining (26) . Using infectivity as a measure of binding, Fig. 1 demonstrates that significantly more ANDV and HTNV (7-to 27-fold) were bound to platelets than TULV (P Ͻ 0.01). These findings demonstrate that platelets selectively bind pathogenic ANDV and HTNV and suggest the potential for platelets to harbor infectious pathogenic hantaviruses. Using a [ (12) . In order to determine if ANDV and HTNV binding to platelets is dependent on ␤ 3 integrins, we incubated hantavirus (10 4 FFU) and platelets (10 6 ) in the presence of an increasing amount of the ␤ 3 integrin-specific Fab fragment c7E3(ReoPro) (10-12) or a control antibody (10 to 100 g/ml). After a wash, hantaviruses bound to platelets were quantitated using the infectivity assay described above. Figure 2A and B indicate that c7E3 inhibited ANDV and HTNV binding to platelets by Ͼ90% while there was no effect of control antibody on viral adherence. Similarly, there was no effect of c7E3 or control antibody on the binding of TULV to platelets. These data demonstrate that pathogenic- (27) , and platelet-rich plasma (PRP) was prepared by centrifugation for 15 min at 1,800 rpm (700 ϫ g) at 25°C. PRP was supplemented with 10 mM EDTA, and platelets were pelleted by centrifugation (15 min at 1,300 ϫ g at 25°C) and washed with HBMT buffer (HEPES-buffered modified Tyrodes buffer; 10 mM HEPES, pH 7.45, 137 mM NaCl, 2.7 mM KCl, 0.4 mM NaH 2 PO 4 , 12 mM NaHCO 3 , 1 mM MgCl 2 , 0.1% dextrose, 0.2% bovine serum albumin [BSA] with 1 M PGE 1 ,10 mM EDTA) (27) . Platelets were purified over a Sepharose 2B column equilibrated with HBMT at room temperature and quantitated using a hemacytometer (27) . Platelets (10 7 or 10 8 per ml) were incubated with 10 4 FFU of HTNV, ANDV, or TULV for 1 h in an incubator at 37°C and 5% CO 2 . Platelets were pelleted and washed three times with 10 volumes of HBMT, resuspended in 100 l HBMT, and then adsorbed onto VeroE6 cells in duplicate wells of a 96-well plate (1 h at 37°C). Monolayers were washed with Dulbecco's modified Eagle's medium supplemented with 2% fetal calf serum, and VeroE6 cells were incubated (37°C, 5% CO 2 ) for 24 h prior to methanol fixation (100%, Ϫ20°C) (24) . The hantavirus nucleocapsid protein present in infected cells was detected by immunoperoxidase staining as previously described, and the number of N protein-containing cells was quantitated (26 (28) . Since pathogenic hantaviruses bind ␤ 3 integrins on endothelial cells and platelets, these findings also suggest that cell surface-displayed hantaviruses may recruit platelets to the surfaces of hantavirus-infected endothelial cells. In order to test this, we labeled purified platelets with calcein AM (Molecular Probes) and evaluated their ability to bind hantavirus-infected endothelial cells. Endothelial cells were infected with HTNV, ANDV, and TULV (multiplicity of infection [MOI] of 0.5) or mock infected for 1 to 3 days. Monolayers were washed, and constant amounts of calcein-labeled platelets were adsorbed to cells. Endothelial cells were washed 3 times to remove nonadherent platelets, and the binding of labeled platelets was visualized and quantitated by fluorescence microscopy (Fig. 3 ). Monolayers were comparably infected with ANDV, HTNV, and TULV as demonstrated by immunoperoxidase staining of the hantavirus nucleocapsid protein from 1 to 3 days postinfection (Fig. 3A) , and platelet aggregation was not observed after binding of platelets to endothelial cells. Platelets are not normally adherent to endothelial cells (12, 34, 44) , and levels of platelet binding to TULVinfected cells were nearly identical to those observed for mock-infected controls at all time points (Fig. 3A and B) . In contrast, there were dramatic increases in platelet adherence to ANDV-and HTNV-infected cells from 1 to 3 days postinfection, with the highest levels of platelet adherence occurring at 3 days postinfection ( Fig. 3A and B) . These results demonstrate that quiescent platelets are recruited to the surface of pathogenic-hantavirus-infected endothelial cells and that platelet binding to infected endothelial cells increases from 1 to 3 days postinfection.
Neutralizing antibodies to ANDV and HTNV specifically inhibit platelet adherence to cells. Hantavirus envelope glycoproteins are trafficked to the cis-Golgi and are not present on the cell surface when recombinantly expressed (33, 46, 54) . Hantaviruses mature by budding into the lumen of the cisGolgi, exiting cells through an incompletely understood vesicular process (54) . In order to determine if platelet adherence to hantavirus-infected endothelial cells is dependent on the presence of cell surface-displayed hantavirus, we evaluated whether neutralizing antibody to ANDV or HTNV blocked platelet adherence to infected cells. Endothelial cells were infected with ANDV, HTNV, or TULV or mock infected, and at 3 days postinfection, endothelial cells were pretreated with neutralizing antibody to ANDV (62), HTNV, or control serum for 1 h on ice. Subsequently, calcein-labeled platelets (10 7 / well) were added to monolayers, and platelet adherence was evaluated as described above (Fig. 4A and B) . Neutralizing anti-ANDV or anti-HTNV sera decreased platelet adherence to only cognate ANDV-or HTNV-infected endothelial cells, respectively (Ͼ5-fold; P Ͻ 0.005), and had no effect on platelet binding to endothelial cells infected with a different hantavirus ( Fig. 4A and B) . Platelet adherence to ANDV-or HTNVinfected cells was unaltered by a control antibody, and there was no change in platelet adherence to TULV-or mock-infected cells following pretreatment with control, anti-ANDV, or anti-HTNV sera ( Fig. 4A and B) . This finding indicates that platelet binding to ANDV-and HTNV-infected endothelial cells is directed by virus present on the endothelial cell surface. These findings are consistent with electron microscopy findings indicating that pathogenic SNV coats the surfaces of infected cells days after infection (28) and suggest that pathogenic hantaviruses fundamentally alter the normal adherence properties of endothelial cells.
␤3 integrin antibodies inhibit platelet adherence to hantavirus-infected endothelial cells. Pathogenic hantaviruses bind basal forms of ␤ 3 integrins (49, 67), and as a result, ␤ 3 integrins are likely to mediate the cell surface display of pathogenic hantaviruses and the concomitant adherence of platelets to infected cells. We hypothesized that pretreatment of infected monolayers with monovalent ␤ 3 integrin Fab fragments might displace pathogenic hantaviruses from the endothelial cell surface and thus abolish the adherence of platelets to infected endothelial cells. To address this, endothelial cells were infected with ANDV, HTNV, or TULV (MOI of 0.5) or mock infected, and at 3 days postinfection, cells were pretreated with FIG. 2. Pathogenic-hantavirus binding to platelets is inhibited by ␤ 3 integrin antibodies. Platelets (10 6 ) were incubated with increasing concentrations of the c7E3(ReoPro) Fab fragment (10) directed at ␣v␤3 or control antibody (anti-␤ 5 integrin [product no. 1926; Chemicon]) (10 to 100 g/ml) or mock treated. Subsequently, platelets were incubated with ANDV, HTNV, or TULV (10 4 FFU) for 2 h at room temperature in HBMT. Following centrifugation and washing 3 times with HBMT to remove unbound virus, platelets were resuspended and adsorbed to VeroE6 cells as described in the legend to Fig. 1 . The number of nucleocapsid protein-positive cells is presented as a percentage of the number of mock-treated infected cells (26) . Results from two independent experiments are presented.
FIG. 3. Platelets adhere to pathogenic-hantavirus-infected endothelial cells. Human umbilical vein endothelial cells were purchased from
Cambrex and seeded onto 96-well plates at a cell density of 2 ϫ 10 4 cells and grown in endothelial basal medium 2 (Cambrex) containing 10% fetal calf serum, as previously described (25) . Confluent endothelial cells were infected in duplicate with HTNV, ANDV, and TULV at an MOI of 0.5 or mock infected. Platelets were purified as described in the legend to an anti-␤ 3 c7E3(ReoPro) Fab fragment (100 ng/ml) (10) or control serum for 1 h on ice. Complete ␤ 3 antibodies were not used, in order to prevent the direct cross-linking of endothelial cell and platelet ␤ 3 integrins. After antibody removal and monolayer washing, calcein-labeled platelets (10 7 /well) were added to endothelial cells and platelet adherence was evaluated as described above (Fig. 5) . Pretreatment of ANDV-and HTNV-infected endothelial cells with c7E3 decreased platelet adherence to cells Ͼ5-fold (P Ͻ 0.005) in comparison to infection alone or pretreatment of infected cells with control antibodies (Fig. 5) . These findings suggest a primary role for ␤ 3 integrins in the cell association of pathogenic hantaviruses and further indicate that ␤ 3 integrin antibodies are capable of inhibiting hantavirus recruitment of platelets to the surface of infected endothelial cells.
The normal function of endothelial cells and platelets is determined by receptor interactions, and ␤ 3 integrins play prominent roles in platelet activation, endothelial cell adherence, and regulation of vascular integrity (6, 8, 10, 12, 29, 30, 32, 38, 53, 56, 63) . Approximately 80,000 copies of ␤ 3 integrin receptors are present on each platelet, making ␤ 3 integrins the most abundantly expressed platelet receptor and providing for rapid platelet activation (12) . ␤ 3 integrins on endothelial cells perform discrete functions that direct vascular repair, angiogenesis, and endothelial cell migration cued by VEGF (6, 7, 18, 19, 30, 41, 50, 53, 56, 63) . These functions in platelets and endothelial cells control vascular integrity through platelet activation and adherence to injured endothelium and by regulating permeabilizing responses of VEGF (6, 12, 18, 20-22, 30, 53) . However, pathogenic hantaviruses bind inactive basal conformations of ␣ v ␤ 3 integrins on endothelial cells (49) , and the findings presented here demonstrate that pathogenic ANDV and HTNV bind ␤ 3 integrins present on the surface of platelets. This finding provides a new role for platelet integrins on December 31, 2017 by guest http://jvi.asm.org/ during hantavirus infection and suggests that platelets may disseminate pathogenic hantaviruses within patients. Hantavirus binding to inactive ␤ 3 integrins also suggests a means by which hantaviruses could prevent normal platelet activation and is consistent with data indicating that platelets from HFRS patients are defective in platelet activation (14) . The binding of activated platelets to endothelial cells is of central importance to the regulation of vascular permeability and hemorrhagic disease, yet platelets normally do not bind endothelial cells and are maintained in a quiescent state by factors (ADPase and PGE 1 ) secreted by endothelial cells (34, 44) . This becomes interesting when findings on pathogenichantavirus use of ␤ 3 integrins are combined with the obscure observation that pathogenic SNV is cell associated and displayed on the surfaces of infected VeroE6 cells (28) , which also express ␣ v ␤ 3 . These observations suggested that cell surfacedisplayed hantaviruses could potentially interact with platelet ␤ 3 integrins and thereby recruit platelets to the surface of endothelial cells. Data presented here indicate that pathogenichantavirus-infected endothelial cells are able to bind quiescent platelets and that binding increased from 1 to 3 days postinfection (Fig. 3) . Figure 4 demonstrates that neutralizing antibodies to ANDV or HTNV selectively blocked the binding of platelets to infected endothelial cells, and this indicates that cell surface-associated virus mediates platelet binding. These findings suggest that at late times postinfection, hantaviruses that are displayed on the surfaces of infected endothelial cells recruit platelets to the endothelial cell surface and thereby form a platelet covering on the surface of the endothelium. This could dramatically alter the appearance of infected endothelial cells to immune cells and enhance viral evasion of immune responses. Since endothelial cell factors prevent platelet activation (29, 34, 42, 44) , recruiting inactive platelets to infected endothelial cells may further contribute to maintenance of platelet quiescence.
Prevention of platelet activation is entirely different from platelet aggregation directed by dengue virus infection and other viral infections associated with thrombocytopenia (36, 48, 61) . Activation of platelets results in aggregation and granule deposition as well as immune cell recruitment and activation of damaged endothelium (1, 3, 60, 66) . Consistent with dengue virus infection, platelet deposition and aggregation may result in thrombocytopenia by reducing the effective concentration of platelets in circulation (36) . In contrast, the absence of platelet activation following hantavirus infection (14) could result in thrombocytopenia due to the transduction of platelet-rich serum into tissues. Recruitment of quiescent platelets to infected endothelial cells suggests a second mechanism by which hantaviruses may cause thrombocytopenia. The endothelium is estimated to contain 10 11 cells and to cover an area of Ͼ1,000 m 2 (1, 60) , and thus, recruitment of quiescent platelets to hantavirus-infected endothelial cells could be a significant means of reducing the level of circulating platelets following infection.
The presence of pathogenic hantaviruses on the surfaces of endothelial cells also suggests that hantavirus ␤ 3 integrin receptor interactions may alter endothelial cell functions. Interestingly, increased platelet adherence to ANDV-and HTNV-infected cells occurs synchronously with the inhibition of ␤ 3 -directed endothelial cell migration (23) and the enhanced permeability of ANDV-and HTNV-infected endothelial cells in response to VEGF (25) . This mimics the enhanced permeability of ␤ 3 integrin knockout endothelial cells in response to VEGF (53) and functionally suggests that cell-associated hantaviruses might contribute to this response. Based on platelet adherence, Fab fragments directed at ␤ 3 appear to remove hantavirus from the cell surface. Although there is no information on whether this prevents hantavirus-induced endothelial cell permeability, ␤ 3 Fab fragments have the potential to normalize ␤ 3 integrin regulation of VEGF responses (10-12) and prevent endothelial cell permeability.
A layer of platelets on the surfaces of endothelial cells may also alter capillary permeability by affecting gas exchange within vast pulmonary capillary beds and thereby contribute to a hypoxic state (4, 16, 57) . Hantavirus patients are hypoxic, and high-altitude-induced pulmonary edema results from hypoxic conditions inducing VEGF (4, 16, 31, 47) . Since hypoxia-induced factor 1␣ (HIF1␣) induces VEGF and VEGF induces transcription of HIF1␣, an autocrine loop which amplifies endothelial cell permeability in response to hypoxia is formed (16, 47, 57, 59) . The importance of these interactions during hantavirus infection is fostered by understanding that hantaviruses inactivate ␤ 3 functions that normally regulate VEGF responses.
Collectively, our findings indicate that hantavirus binding to inactive ␤ 3 integrins affects both platelet and endothelial cell interactions which dynamically regulate vascular integrity. Our data suggest a new paradigm in which pathogenic hantaviruses alter the endothelial cell surface as well as endothelial cell functions through the recruitment and display of quiescent platelets and further suggest a potential means for therapeutic intervention by the targeting of these receptors.
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